Investigational Site 012 — Lynchburg, Virginia

Investigational Site 012 is a clinical research site located in Lynchburg, Virginia, United States 24501.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site 012 has participated in 1 clinical trials.

Therapeutic areas: Clostridium Difficile Infection.

Sponsors: Sanofi Pasteur, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lynchburg

Browse all research sites in Virginia · View every site in Lynchburg

• Virginia Baptist Hospital
• Centra Lynchburg General Hospital
• Centra Medical Group Stroobants Cardiovascular Center, Centra Lynchburg General Hospital
• Liberty University
• Centra Health- Lynchburg General Hospital
• Lynchburg General Hospital
• Centra Alan B Pearson Regional Cancer Center
• Piedmont Eye Center
• Blue Ridge Medical Research
• Lynchburg Hematology-Oncology Clinic
• The Education & Research Foundation
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 012?

Investigational Site 012 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 012 conducted?

Investigational Site 012 has 1 clinical trials on record. Their work covers Clostridium Difficile Infection.

Is Investigational Site 012 accredited by Crixeo Clinical Trials?

Investigational Site 012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.